LON:VEC Vectura Group Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Vectura Group plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 164.80 0.00 (0.00%) (As of 10/18/2021) Add Compare Share Today's Range 164.63▼ 16550-Day Range 164.80▼ 164.8052-Week Range 100▼ 176Volume203,761 shsAverage Volume3.37 million shsMarket Capitalization£1.01 billionP/E Ratio8.20Dividend Yield23.06%Price TargetGBX 150 ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesOptions Chain Vectura Group MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside9.0% DownsideGBX 150 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.94 out of 5 stars 1.0 Analyst's Opinion Consensus RatingVectura Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 150, Vectura Group has a forecasted downside of 9.0% from its current price of GBX 164.80.Amount of Analyst CoverageVectura Group has received no research coverage in the past 90 days. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for VEC. Previous Next 1.7 Dividend Strength Dividend LeadershipVectura Group is a leading dividend payer. It pays a dividend yield of 23.06%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthVectura Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Vectura Group is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for VEC. Previous Next 1.1 News and Social Media Coverage News SentimentVectura Group has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vectura Group insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Vectura Group is 8.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 91.21.Price to Earnings Ratio vs. SectorThe P/E ratio of Vectura Group is 8.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 69.50.Price to Book Value per Share RatioVectura Group has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive VEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter. Email Address About Vectura Group (LON:VEC) StockVectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.Read More VEC Stock News HeadlinesJune 21, 2022 | apnews.comQurAlis Announces the Appointment of Anne C. Whitaker as Chair of the BoardJune 7, 2022 | marketwatch.comAerosol Delivery Devices Market 2022-2027: Size, Share, Analysis and Future ScopeMay 4, 2022 | benzinga.comOutlook on the Smart Inhalers Global Market to 2030 - Featuring Aptar Group, AstraZeneca and Cognita Labs Among OthersApril 25, 2022 | seekingalpha.comPhilip Morris International's (PM) CEO Jacek Olczak on Q1 2022 Results - Earnings Call TranscriptMarch 1, 2022 | finance.yahoo.comMereo BioPharma Announces Appointment of Anne Hyland to Board of DirectorsDecember 22, 2021 | marketwatch.comTop 10 Nasal Drug Delivery Market Companies to Watch Post-COVIDNovember 9, 2021 | msn.comBritcoin at least five years away, says Bank of EnglandOctober 1, 2021 | msn.comMorrisons sells the pass: Both of the bidders for the supermarket group would make unsuitable owners, says ALEX BRUMMEROctober 1, 2021 | msn.comBRIEF-Philip Morris Receives Valid Acceptances Of Offer In Respect Of About 96.86% Of Vectura SharesSeptember 30, 2021 | theglobeandmail.comTakeover battle for supermarket group Morrisons will go to U.K. auction on Oct. 2September 17, 2021 | finance.yahoo.comPhilip Morris (PM) Secures More than 74% Stake in VecturaSeptember 17, 2021 | msn.comVectura barred from major medical conference after Philip Morris takeoverSeptember 16, 2021 | msn.comMarlboro man seals Vectura deal: Fury as shareholders vote through cigarette maker's £1bn takeover of asthma inhaler firmSeptember 16, 2021 | bloomberg.comPhilip Morris Secures Shares Needed for Vectura AcquisitionSeptember 16, 2021 | msn.comContentious takeover of Vectura by Philip Morris is clinchedSeptember 13, 2021 | msn.comTobacco giant's takeover bid could affect COPD lung disease treatment and research in AustraliaSeptember 12, 2021 | uk.finance.yahoo.comBlock Vectura takeover, Philip Morris investors urgedSeptember 8, 2021 | theglobeandmail.comTakeover battle for British supermarket group Morrisons heads for auctionSeptember 8, 2021 | uk.finance.yahoo.comNorges Bank - Form 8.3 - Vectura Group PlcAugust 31, 2021 | finance.yahoo.comForm 8.3 - VECTURA GROUP PLC - 20210827August 19, 2021 | lse.co.ukPhilip Morris lifts Vectura stake to 29%, halts further market tradesAugust 19, 2021 | marketwatch.comPhilip Morris Raises Vectura Stake to 29.16%; Doesn't Plan Further PurchasesAugust 18, 2021 | nasdaq.comPhilip Morris Acquires 22.6% Stake In VecturaAugust 18, 2021 | msn.comMarlboro maker tightens grip on Vectura ahead of £1bn takeoverAugust 18, 2021 | finance.yahoo.comForm 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210816See More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolLON:VEC CUSIPN/A CIKN/A Webwww.vectura.com Phone+44-1249-667700FaxN/AEmployees9,200Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 150 High Stock Price ForecastGBX 150 Low Stock Price ForecastGBX 150 Forecasted Upside/Downside-9.0%Consensus RatingHold Rating Score (0-4)2 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio8.20 Forward P/E Ratio0.18 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.77 Current Ratio3.59 Quick Ratio3.20 Sales & Book Value Annual Sales£190.60 million Price / Sales5.31 Cash FlowGBX 13.20 per share Price / Cash Flow12.48 Book ValueGBX 91.70 per share Price / Book1.80Miscellaneous Outstanding Shares613,892,000Free FloatN/AMarket Cap£1.01 billion OptionableOptionable BetaN/A Vectura Group Frequently Asked Questions Should I buy or sell Vectura Group stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Vectura Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VEC, but not buy additional shares or sell existing shares. View analyst ratings for Vectura Group or view top-rated stocks. What is Vectura Group's stock price forecast for 2022? 2 brokers have issued twelve-month price objectives for Vectura Group's stock. Their VEC stock forecasts range from GBX 150 to GBX 150. On average, they anticipate Vectura Group's share price to reach GBX 150 in the next twelve months. This suggests that the stock has a possible downside of 9.0%. View analysts' price targets for Vectura Group or view top-rated stocks among Wall Street analysts. How has Vectura Group's stock price performed in 2022? Vectura Group's stock was trading at GBX 164.80 at the beginning of 2022. Since then, VEC shares have increased by 0.0% and is now trading at GBX 164.80. View the best growth stocks for 2022 here. Is Vectura Group a good dividend stock? Vectura Group(LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Vectura Group is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable. View Vectura Group's dividend history. Who are Vectura Group's key executives? Vectura Group's management team includes the following people: Mr. William Downie, CEO & Exec. Director (Age 54, Pay $538.92k)Mr. Paul Andrew Fry, CFO & Exec. Director (Age 54, Pay $807k)Mr. Anthony Fitzpatrick, Exec. VP of OperationsDr. Geraldine Venthoye, Chief Scientific Officer & Exec. VP of Product Devel.Elizabeth Knowles, VP of Investor RelationsMr. John Murphy, Gen. Counsel & Company Sec. (Age 68)David Ginivan, VP of Corp. CommunicationsMs. Christina Olsen, Exec. VP of Corp. Strategy & CommunicationsMs. Joanne Hombal, Exec. VP of HR (Age 47)Mr. Roger Heerman, Exec. VP of Commercial & Bus. Devel. (Age 48) Who are some of Vectura Group's key competitors? Some companies that are related to Vectura Group include HUTCHMED (HCM), Beximco Pharmaceuticals (BXP), Sareum (SAR), Allergy Therapeutics (AGY), Futura Medical (FUM), ECO Animal Health Group (EAH), Trilogy International Partners (TRL), Cathay International Holdings Limited (CTI.L) (CTI), Avivagen (VIV), N4 Pharma (N4P), Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group (MYX) and Medical Developments International (MVP). View all of VEC's competitors. What other stocks do shareholders of Vectura Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT). What is Vectura Group's stock symbol? Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC." How do I buy shares of Vectura Group? Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Vectura Group's stock price today? One share of VEC stock can currently be purchased for approximately GBX 164.80. How much money does Vectura Group make? Vectura Group (LON:VEC) has a market capitalization of £1.01 billion and generates £190.60 million in revenue each year. How many employees does Vectura Group have? Vectura Group employs 9,200 workers across the globe. How can I contact Vectura Group? Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The official website for Vectura Group is www.vectura.com. The company can be reached via phone at +44-1249-667700. This page (LON:VEC) was last updated on 7/7/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
